Review Article

Phages and their application against drug-resistant bacteria

  1. N Chanishvili1,*,
  2. T Chanishvili1,
  3. M Tediashvili1,
  4. P A Barrow2

Article first published online: 19 JUN 2001

DOI: 10.1002/jctb.438

Issue

Journal of Chemical Technology and Biotechnology

Journal of Chemical Technology and Biotechnology

Volume 76, Issue 7, pages 689–699, July 2001

Additional Information

How to Cite

Chanishvili, N., Chanishvili, T., Tediashvili, M. and Barrow, P. (2001), Phages and their application against drug-resistant bacteria. J. Chem. Technol. Biotechnol., 76: 689–699. doi: 10.1002/jctb.438

Author Information

  1. 1

    George Eliava Institute of Bacteriophage, Microbiology and Virology, Georgian Academy of Sciences, Tbilisi, Georgia

  2. 2

    Institute for Animal Health, Compton, Newbury, Berkshire R620 7NN, UK

*George Eliava Institute of Bacteriophage, Microbiology and Virology, Georgian Academy of Sciences, Tbilisi, Georgia

Publication History

  1. Issue published online: 19 JUN 2001
  2. Article first published online: 19 JUN 2001
  3. Manuscript Accepted: 13 MAR 2001
  4. Manuscript Received: 12 MAR 2001

Funded by

  • INTAS. Grant Number: GE-97 N1341

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (235K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Patricia Escobar-Páramo, Claire Gougat-Barbera, Michael E. Hochberg, Evolutionary dynamics of separate and combined exposure of Pseudomonas fluorescens SBW25 to antibiotics and bacteriophage, Evolutionary Applications, 2012, 5, 4
    Direct Link:
  2. 2
    Quan-Guo Zhang, Angus Buckling, Phages limit the evolution of bacterial antibiotic resistance in experimental microcosms, Evolutionary Applications, 2012, 5, 4
    Direct Link:
  3. 3
    Leila Kvachadze, Nana Balarjishvili, Tamila Meskhi, Ekaterine Tevdoradze, Natia Skhirtladze, Tamila Pataridze, Revaz Adamia, Temur Topuria, Elizabeth Kutter, Christine Rohde, Mzia Kutateladze, Evaluation of lytic activity of staphylococcal bacteriophage Sb-1 against freshly isolated clinical pathogens, Microbial Biotechnology, 2011, 4, 5
    Direct Link:
  4. 4
    Muntasir Alam, Marufa Zerin Akhter, Mahmuda Yasmin, Chowdhury Rafiqul Ahsan, Jamalun Nessa, Local bacteriophage isolates showed anti-Escherichia coliO157:H7 potency in an experimental ligated rabbit ileal loop model, Canadian Journal of Microbiology, 2011, 57, 5, 408

    CrossRef

  5. 5
    Dipankar Ghosh, Arindam Pramanik, Narattam Sikdar, Panchanan Pramanik, Synthesis of low molecular weight alginic acid nanoparticles through persulfate treatment as effective drug delivery system to manage drug resistant bacteria, Biotechnology and Bioprocess Engineering, 2011, 16, 2, 383

    CrossRef

  6. 6
    Mzia Kutateladze, Revaz Adamia, Bacteriophages as potential new therapeutics to replace or supplement antibiotics, Trends in Biotechnology, 2010, 28, 12, 591

    CrossRef

  7. 7
    Stéphan Jacquet, Takeshi Miki, Rachel Noble, Peter Peduzzi, Steven Wilhelm, Viruses in aquatic ecosystems: important advancements of the last 20 years and prospects for the future in the field of microbial oceanography and limnology, Advances in Oceanography and Limnology, 2010, 1, 1, 97

    CrossRef

  8. 8
    Long Yu, Zhanbo Wen, Jinsong Li, Wenhui Yang, Jie Wang, Na Li, Jianchun Lu, Effects of different sampling solutions on the survival of bacteriophages in bubbling aeration, Aerobiologia, 2009, 26, 1, 75

    CrossRef

  9. 9
    Geoffrey William Hanlon, Bacteriophages: an appraisal of their role in the treatment of bacterial infections, International Journal of Antimicrobial Agents, 2007, 30, 2, 118

    CrossRef

  10. 10
    Maia Merabishvili, Rita Verhelst, Thea Glonti, Nino Chanishvili, Victor Krylov, Claude Cuvelier, Marina Tediashvili, Mario Vaneechoutte, Digitized fluorescent RFLP analysis (fRFLP) as a universal method for comparing genomes of culturable dsDNA viruses: application to bacteriophages, Research in Microbiology, 2007, 158, 7, 572

    CrossRef

  11. 11
    Bin SONG, Hong-yan XIONG, Yan XU, Xiang-yu MA, Lu ZHANG, Isolation of a novel polyvalent virulent bacteriophage of E. coli, Journal of Medical Colleges of PLA, 2007, 22, 5, 261

    CrossRef

  12. 12
    David T. Kysela, Paul E. Turner, Optimal bacteriophage mutation rates for phage therapy, Journal of Theoretical Biology, 2007, 249, 3, 411

    CrossRef

  13. 13
    R. Efrony, Y. Loya, E. Bacharach, E. Rosenberg, Phage therapy of coral disease, Coral Reefs, 2006, 26, 1, 7

    CrossRef

  14. 14
    G. O'Flynn, A. Coffey, G.F. Fitzgerald, R.P. Ross, The newly isolated lytic bacteriophages st104a and st104b are highly virulent against Salmonella enterica, Journal of Applied Microbiology, 2006, 101, 1
    Direct Link:
  15. 15
    S. Withey, E. Cartmell, L.M. Avery, T. Stephenson, Bacteriophages—potential for application in wastewater treatment processes, Science of The Total Environment, 2005, 339, 1-3, 1

    CrossRef

  16. 16
    Jason R Clark, John B March, Bacterial viruses as human vaccines?, Expert Review of Vaccines, 2004, 3, 4, 463

    CrossRef

  17. 17
    G. Hitch, J. Pratten, P.W. Taylor, Isolation of bacteriophages from the oral cavity, Letters in Applied Microbiology, 2004, 39, 2
    Direct Link:
  18. 18
    Richard J. Weld, Christine Butts, Jack A. Heinemann, Models of phage growth and their applicability to phage therapy, Journal of Theoretical Biology, 2004, 227, 1, 1

    CrossRef

  19. 19
    K. Verth�, S. Possemiers, N. Boon, M. Vaneechoutte, W. Verstraete, Stability and activity of an Enterobacter aerogenes-specific bacteriophage under simulated gastro-intestinal conditions, Applied Microbiology and Biotechnology, 2004, 65, 4, 465

    CrossRef

  20. 20
    Robert J.H. Payne, Vincent A.A. Jansen, Pharmacokinetic Principles of Bacteriophage Therapy, Clinical Pharmacokinetics, 2003, 42, 4, 315

    CrossRef

View Full Article (HTML) Get PDF (235K)